• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

I'm Feeling Optimistic About IBM, But It's Still a Trade

I kind of liked these earnings. CEO Krishna is on the right track.
By STEPHEN GUILFOYLE
Apr 20, 2022 | 10:50 AM EDT

Can it be? A positive looking quarter from International Business Machines  (IBM) ? My, how times have changed.

Ever since CEO Arvind Krishna took the position of chief executive in April of 2020 (Krishna took the Chair in January of 2021), he has taken the firm in a more focused direction. Late last year, IBM rid itself of the legacy technology infrastructure business with the Kyndryl Holdings (KD) spin-off. Early feedback feels... kind of optimistic.

Performance

For the firm's first quarter, IBM posted adjusted EPS of $1.40 (+24.4%) on revenue of $14.2B. The sales number beat Wall Street and was good enough for 7.7% annual growth over last year's (adjusted for the KD separation) result. Breaking the performance out by segment...

Software (includes Hybrid Platform & Solutions, Transaction Processing)... revenue of $5.772B, up 12.3% (over 8 points from incremental sales to Kyndryl) producing a gross margin of 78.8%.

- Hybrid Platform sales up 7%

- Red Hat +18%

- Automation +3%

- Data & AI +2%

- Security +5%

- Transaction Processing sales up 26%

* Software Segment hybrid cloud revenue +22%

Consulting (includes Business Transformation, Technology Consulting and Appreciation Operations)... revenue of $4.829B, up 13.3% producing a gross margin of 24.3%.

- Business Transformation sales up 15%

- Technology Consulting sales up 14%

- Appreciation Operations sales up 10%

* Consulting Segment hybrid cloud revenue +24%

Infrastructure (includes Hybrid infrastructure, Infrastructure Support)... revenue of $3.219B, down 2.3% (over 8 points from incremental sales to Kyndryl) producing a gross margin of 50.5%.

- Hybrid Infrastructure sales down 5% (over 8 points from incremental sales to Kyndryl)

- IBM z Systems -19%

- Distributed Infrastructure +5%

- Infrastructure Support flat (+/- 0%) (over 8 points from incremental sales to Kyndryl)

* Infrastructure Segment hybrid cloud revenue -20%

CEO Krishna added a comment to the press release... "Demand for hybrid cloud and AI drove growth in both Software and Consulting in the first quarter. Today we're a more focused business and our results reflect the execution of our strategy. We are off to a solid start for the year, and we now see revenue growth for 2022 at the high end of our model."

As far as that model is concerned, the firm expects to experience FY 2022 constant currency revenue growth at the high end of the mid-single digit range. IBM also expects to see an additional 3.5 point contribution from incremental sales to Kyndryl. IBM also continues to expect $10B to $10.5B in consolidated free cash flow this year.

CFO James Kavanaugh added, "We are a faster growing, more profitable company with a higher-value business mix, a significant recurring revenue base and strong cash generation."

Wall Street

I can find five sell-side analysts rated at either four or five stars by TipRanks that have also opined on IBM since these earnings were released. Among the five, there are three "buy" or "buy equivalent" ratings, and two "hold" or "hold equivalent" ratings. The average target price of the five is $157.60, with a high of $166 (Sami Badri of Credit Suisse), and a low of $140 (Amit Daryanani of Evercore ISI).

Just an aside here... I don't know if Lisa Elis of MoffettNathanson is going to opine on these earnings. Elis is rated at five stars by TipRanks and is one of my favorite analysts in the space. If my information is up to date, Elis last opined on IBM on January 25th (Q4 earnings) when she reiterated a "sell" rating on IBM with a target price of $115. I would love to see if Elis finds some of the same improving optimism in IBM this time around as I do, as I greatly respect her opinion.

Balance Sheet

IBM ended the first quarter with a net cash position of $9.934B, and current assets of $31.33B. Both of these entries grew nicely over the past 12 months. Total current liabilities grew (not as much) as well to $34.056B, as short-term debt grew to $7.69B. Long-time readers know full well that a current ratio of 0.92 gives me some agita. I really, really like to see that ratio rise above the "1" level before I can get enthusiastic, and I like to see it comfortably above that level.

Total assets of $133.275B (that includes $56.106B in "goodwill" and $12.312 in "net intangibles for $68.418 in non-quantifiable assets) dwarf total liabilities of $114.162B of which $46.545B is accounted for as long-term debt. The debt is real. Can one count on intangible assets? Not that they don't exist, they do. But... Can you count on them. I'm sorry. I do have an optimistic feel for IBM for the first time in a long time. That said, this balance sheet is not yet fixed and it does not yet pass the Sarge test.

My Thoughts

Readers will see what these shares are at least short-term overbought. The daily MACD looks okay, but relative strength is becoming extended. I kind of liked these earnings. I think that Krishna is on the right track. There is more work to do. Perhaps for me, IBM is still a quarter (or less) away. For right now, I would love to be able to get a short off for a trade as close to $141 as possible. I probably go as low as $137. My point is that IBM is better, but for now, for me, it's still just a trader.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Stephen Guilfoyle had no position in the securities mentioned.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Trading | Fintech | Software & Services

More from Investing

Barring a Major Recession, Some Chip Stocks Look Very Cheap Right Now

Eric Jhonsa
Jun 30, 2022 11:45 AM EDT

Many quality chip stocks now seem to be pricing in a massive downturn, rather than just a typical down-cycle.

RH Stock: What Would It Take to Restore the Uptrend?

Bruce Kamich
Jun 30, 2022 11:30 AM EDT

Let's check out the charts of the specialty retailer hit by lowered guidance.

Fears of a Recession Are Building

James "Rev Shark" DePorre
Jun 30, 2022 11:16 AM EDT

However, I'm anticipating some bounces and increased volatility this afternoon as money managers make last-second moves to close out the second quarter.

My Setup for the Second Half of 2022 Begins With These 13 Stock Picks

Stephen Guilfoyle
Jun 30, 2022 11:00 AM EDT

I'm setting up for the next six months with selections in Energy, Staples, Semiconductors, and Aerospace & Defense.

As Biotechs Seem to Have Bottomed, Here Are 3 to Consider

Bret Jensen
Jun 30, 2022 10:15 AM EDT

I expect biotech M&A activity to pick up in the back half of 2022.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login